DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02010411 (ClinicalTrials.gov)	June 2004	9/12/2013	Alpha1 Antitrypsin Aerosol Therapy in Cystic Fibrosis	Effects of Prolastin Aerosol Therapy on Bacterial Density in the Airways of Patients With Cystic Fibrosis	Cystic Fibrosis	Drug: Prolastin (drug)	Université de Sherbrooke	NULL	Terminated	14 Years	N/A	Both	17	Phase 2	Canada

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

June 2004

9/12/2013

Alpha1 Antitrypsin Aerosol Therapy in Cystic Fibrosis

Effects of Prolastin Aerosol Therapy on Bacterial Density in the Airways of Patients With Cystic Fibrosis

Cystic Fibrosis

Drug: Prolastin (drug)

Université de Sherbrooke

NULL

Terminated

14 Years

N/A

Both

Phase 2

Canada